Klaus Geissler, Eva Jäger, Agnes Barna, Thamer Sliwa, Paul Knöbl, Ilse Schwarzinger, Heinz Gisslinger, and Peter Valent. 2016. “Is Ruxolitinib a Potentially Useful Drug in Hematological Malignancies With RAS Pathway Hyperactivation?”. Haematologica 101 (12). Pavia, Italy, e492-e492. https://doi.org/10.3324/haematol.2016.156448.